GlassScriptPhysician profile
Francis K Firestone
NPI 1982958062
$6,755.03
in general payments reported to CMS, 2019-2025
21 companies · $1,520 in 2025
The $1,520 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $1,200 · 2023: $1,673 · 2024: $2,136 · 2025: $1,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,392 · Travel and Lodging: $1,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,392.02 |
| Travel and Lodging | $1,936.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,296.70 | 2024 | Spoton, Prevena, 3m Skin and Nasal Antiseptic |
| Reel Surgical, INC. | $1,200.00 | 2022 | |
| Medical Device Business Services, INC. | $1,192.85 | 2023 | |
| Mentor Worldwide LLC | $1,118.57 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $398.78 | 2023-2025 | |
| Organogenesis INC. | $340.13 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise, Affinity |
| Integra Lifesciences Corporation | $279.24 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Axogen | $243.83 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $116.18 | 2023 | Camzyos |
| Ethicon US, LLC | $103.58 | 2025 | Ethicon, Vistaseal |
| Horizon Therapeutics Plc | $59.09 | 2021 | |
| Stryker Corporation | $51.42 | 2021-2025 | Spy-Phi System |
| Avita Medical Americas, LLC | $50.05 | 2025 | Cohealyx, Recell, Permeaderm |
| Depuy Synthes Sales INC. | $43.81 | 2025 | Matrixmandible |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $31.89 | 2023-2024 | Tisseel |
| Kerecis Limited | $22.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $22.17 | 2024 | Exparel |
| Arteriocyte Medical Systems, INC. | $22.00 | 2021 | |
| Kci USA, INC. | $19.20 | 2023 | Promogran Prisma, Activ.A.C. |
| Smith+Nephew, INC. | $18.03 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Firestone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.